Stromedix
Cambridge
About Stromedix
Stromedix will focus initially on chronic indications but plans to leverage its expertise and expand its therapeutic pipeline into related settings such as acute organ failure and cancer.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $28.0M
- Funding stage: M&A
- Last round: Series C (Jan 2011)
- Website: stromedix.com
- Phone: +1 617.674.8400
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/stromedix-3802047 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.